Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Triple-blind, Randomized, Placebo-controlled, Multi-center Study on the Effect of BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection

NCT01202630 is registered in ClinicalTrials.gov with Bio-K Plus International Inc. as lead sponsor.

NCT NCT01202630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01202630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Triple-blind, Randomized, Placebo-controlled, Multi-center Study on the Effect of BIO-K+ CL1285 for Prevention of Recurrent Clostridium Difficile Infection
Lead sponsor
Bio-K Plus International Inc.
Phase
Phase 3
Overall status
Suspended
Start date
June 30, 2010
Completion date
January 31, 2016
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent clostridium difficile infection